Insights & Analysis
There’s one constant in healthcare: change. Count on us to break down the trends so you can stay up to date. Follow our take on each piece of this deep, intertwined, and often perplexing industry to find opportunities and practical approaches to move healthcare forward.
Featured Content
Premium Content
Premium Content
Disease Matters: Comparing Prescription Drug Benefits in Covered California Plans
A new report by Avalere Health published by the California HealthCare Foundation
2015 Industry Outlook
Avalere hosted its 2015 Outlook webinar last week, which featured Tanisha Carino, Lindy Hinman, Ellen Lukens and Josh Seidman.
Avalere Analysis: Exchange Benefit Designs Increasingly Place All Medications for Some Conditions on Specialty Drug Tier
New analysis from Avalere Health finds that some exchange plans place all drugs used to treat complex diseases - such as HIV, cancer, and multiple sclerosis - on the highest drug formulary cost-sharing tier.
Avalere Medicaid Expansion Map – February 2015
28 States & DC Are Expanding Medicaid Eligibility; Others May Decide to Expand
Avalere’s Take: President Obama’s FY2016 Healthcare Budget
Today, the President released his Budget for the 2016 Fiscal Year. Avalere Health offers the following observations.
Avalere White Paper: A Multi-Stakeholder Vision for Patient-Centeredness in New Payment and Delivery Models
Avalere released its latest white paper on patient-reported outcomes (PROs) today in collaboration with leaders from patient, payer, health information technology, product development and research communities.
HHS Sets Specific Targets and Timelines for Alternative Payment Models and Value-Based Payment
On Monday, January 26, Secretary Burwell announced a goal to have half of Medicare fee-for-service payment in alternative payment models (APMs) by 2018.
Avalere Observations on the 21st Century Cures Discussion Draft
The House Energy and Commerce Committee released a legislative discussion draft yesterday as part of its 21st Century Cures initiative.
ASCO Prepares to Launch Big Data Cancer Quality Initiative
Avalere published an article this week on ASCO's plan to launch CancerLinQ™.
Avalere’s Take: Exchange Open Enrollment Figures to Date
With less than a month to go in 2015 exchange open enrollment, the Department of Health and Human Services (HHS) today released new estimates of sign-ups to date. But where do we really stand?
Avalere and the Alliance Release Home Health Chartbook
Avalere Health & The Alliance for Home Health Quality & Innovation released a Chartbook as an overview of home health patients, workforce, organizational trends, and economic contributions.
Avalere Analysis: New Benefit Designs in Exchange Plans Make Determining Out-of-Pocket Costs for Specialty Drugs Challenging
Determining the cost or co-payment of a specialty drug-high-cost drugs typically used to treat complex diseases like cancer or rheumatoid arthritis-has always been complicated.
MAP Releases Draft 2014-2015 Measure Recommendations; More Conservative Than in Year’s Past
On Tuesday, December 23, the Measure Applications Partnership (MAP) released draft recommendations for inclusion of measures in federal programs.
Recent Insights from the Avalere Center for Payment & Delivery Innovation
The Avalere Center for Payment & Delivery Innovation is a leading voice in helping organizations succeed in a value-based healthcare environment.
Dialogue Proceedings: Launching the Malnutrition Quality Improvement Initiative
Despite its notable negative impact on patient outcomes and costs of care, malnutrition is an area that has largely remained unaddressed by national programs and initiatives.
New Web Tool Helps Consumers Estimate Out-Of-Pocket Costs In Marketplace Plans
PuttingPatientsFirst.net uses Avalere Analytics to Educate Patients about Exchange Choices
Avalere Analysis – Exchange Enrollment Outlook: 10.5 Million to Sign Up by End of 2015
A new analysis by Avalere Health estimates that exchange enrollment will total 10.5 million people by the end of 2015, though enrollment could fluctuate up or down by approximately 1 million individuals.
Avalere Analysis: Consumers Should Look at Maximum Out-of-Pocket Limits & Deductibles in the Exchanges
New analysis from Avalere Health finds that 74 percent of Silver plans offered on exchanges have maximum out-of-pocket limits below what is required by law.
UDI Lineage – UDIs Not Linked When a Device Changes Ownership, Potentially Causing Patient Harm and Provider Confusion
FDA passed the Final Rule for Unique Device Identification (UDI) on September 24, 2013 with the rollout of Class III devices one year later.
Exchange Plans Increase Costs of Specialty Drugs for Patients in 2015
A new analysis from Avalere Health finds that patients accessing specialty medications - drugs often used to treat life threatening illnesses, such as cancer, rheumatoid arthritis, or multiple sclerosis - through exchange plans are more likely to experience higher out-of-pocket costs in 2015 than in 2014.